BDNF and Alzheimer disease: Furthermore, combination of C21 with memantine, an NMDA antagonist, and therefore glutamate toxicity modulator, used in AD, resulted in even greater levels of BDNF in the brain but no additive effect on CBF or cognition was observed [279].